Literature DB >> 11427943

Replacing factor-dependency with that for lysozyme: affordable culture of IL-6-dependent hybridoma by transfecting artificial cell surface receptor.

M Kawahara1, A Natsume, S Terada, K Kato, K Tsumoto, I Kumagai, M Miki, W Mahoney, H Ueda, T Nagamune.   

Abstract

Cytokines and growth factors are indispensable for the propagation and maintenance of factor-dependent mammalian cells. However, cytokines are often so expensive that the use of factor-dependent cells for industrial applications such as protein production is often not practical. Based on our previous design of a binary hen egg lysozyme (HEL)-specific receptor composed of portions of the anti-HEL antibody and the erythropoietin receptor, a new pair of chimeric receptors having the intracellular domain of gp130 were made and transfected to an interleukin-6 (IL-6)-dependent hybridoma, 7TD1. The clone expressing the two new receptors showed clear HEL dose-dependent cell growth and monoclonal antibody production in both serum-based and serum-free media without IL-6. These results establish the feasibility of applying receptor design to tailor cells for the inexpensive induction of cell growth for the purpose of producing therapeutic products. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427943     DOI: 10.1002/bit.1132

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  2 in total

1.  Bypassing antibiotic selection: positive screening of genetically modified cells with an antigen-dependent proliferation switch.

Authors:  Masahiro Kawahara; Hiroshi Ueda; Sumiyo Morita; Kouhei Tsumoto; Izumi Kumagai; Teruyuki Nagamune
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

2.  Growth control of hybridoma cells with an artificially induced EpoR-gp130 heterodimer.

Authors:  Masahiro Kawahara; Yuko Ogo; Kouhei Tsumoto; Izumi Kumagai; Hiroshi Ueda; Teruyuki Nagamune
Journal:  Cytotechnology       Date:  2006-12-05       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.